How Pharma Dealmaking Can Reveal Tomorrow’s Therapies
The global market for obesity therapeutics has undergone a seismic shift, catalyzed by the rise of GLP-1-based therapies which in turn has driven a surge in strategic dealmaking.
Executive Summary
The Deal Landscape
Growth Drivers
Deep Dives
How Evaluate Helps